🎉 Finosauras is now  SarasRead more
Bafna Pharmaceuticals Ltd logo

Bafna Pharmaceuticals Ltd

(NSE: BAFNAPH)

Sector: Healthcare

Market Cap: 288.37 Cr

123.11

+5.79 (4.70%)

CMP

As on 23 Jan 2026, 03:30 pm

Open
118.00
High
123.18
Low
118.00
Close
123.11
Previous Close
117.32

Returns

PeriodReturn %
1 Month-12.03
3 Months-21.10
1 Year49.22
5 Years-21.54

Last updated on: 09/01/2026, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
M7 GLOBAL FUND PCC-AERION3.21%760,059
M7 GLOBAL FUND PCC - CELL DEWCAP FUND3.12%737,158
ZEAL GLOBAL OPPORTUNITIES FUND3.01%712,586

Last updated on: 12/31/2025, 12:00:00 AM

Technical Data

No data available.

Last updated on: 24/01/2026, 3:30 pm

Latest Market News

Fundamental Data

Fundamental Analysis

P/E Ratio

32.86

P/B Ratio

3.16

PEG Ratio

-0.98

ROE

5.01%

EPS

3.71

Dividend Yield

N/A

Market Cap

288.37 Cr

Sector

N/A

Last Updated: 24 Jan 2026, 02:30 pm

Loading peer comparison...

About : Bafna Pharmaceuticals Ltd.

Incorporated Year

1995

City and State

Chennai, Tamil Nadu

Listing Date

Director's Name

Vinayak Dinesh Dendukuri

Revenue

145.86 Cr

Net Profit

4.15 Cr

FAQs